Among the top 15 pharma companies, AbbVie Inc. and Merck & Co. Inc. had the biggest spikes in payments to physicians in 2016, increasing them by 135% and 86%, respectively, while Bristol-Myers Squibb Co. slashed its payments by 80% and Janssen Pharmaceuticals Inc. by 57%, according to figures from the Centers for Medicare & Medicaid Services' Open Payments database.
Merck doled out $301.7m to physicians in 2016, up from $162.4m in 2015 while AbbVie's payments shot up from $72.9m to $171m
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?